This week’s edition of Nature comes with the profile of Gerd Kempermann. He is one of the leaders of the newly opened Center for Regenerative Therapies in Dresden which results from the collaboration of several research groups in Dresden (from the University and the Max Plancks among others) including my own group (as a non core group).

It seems to be an exciting time to be doing oncological research in Dresden and hopefully there will be opportunities for some collaboration with biologists to test a model I have in mind about the role of stem cells in cancer initiation.